Interventional pulmonology

NRMP® Specialties Matching Service® Matched Nearly 12,000 Applicants into Fellowship Programs for the 2024 Appointment Year

Retrieved on: 
星期二, 二月 13, 2024
BSN, Metabolism, Medicine, Growth, Diabetes, Pain management, Doctor of Health Science, MBA, Brain damage, SMS, Gynecologic Oncology (journal), NRMP, Urogynecology, Interventional pulmonology, Forensic pathology, Result, Emergency medical services, Medical genetics, Workforce, Sports medicine, Critical Care Medicine (journal), Nursing

WASHINGTON, Feb. 13, 2024 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released a new data report, the Results and Data Specialties Matching Service®, 2024 Appointment Year, for Fellowship Matches in the Specialties Matching Service® (SMS®). The report shows that 14,034 active applicants submitted a rank order list of programs, competing for 14,169 fellowship positions in 6,116 programs. Of those applicants, 11,853 were matched to a fellowship position, an increase of 305 active applicants from the 2023 appointment year.  

Key Points: 
  • The report shows that 14,034 active applicants submitted a rank order list of programs, competing for 14,169 fellowship positions in 6,116 programs.
  • Of those applicants, 11,853 were matched to a fellowship position, an increase of 305 active applicants from the 2023 appointment year.
  • The number of applicants matched for the 2024 appointment year increased for all applicant types compared to 2023.
  • The number of U.S. MD graduates matched was 6,667, an increase of 110 applicants from the 2023 appointment year.

The Lung Center at Mercy Introduces Interventional Pulmonology

Retrieved on: 
星期三, 一月 3, 2024
Magnet, Weinberg Center, Neuromuscular disease, Body cavity, Multimedia, Division, Sister, Elective surgery, Respiratory disease, Sleep, COPD, The Sisters of Mercy, Lung cancer, Disease, Interventional pulmonology, Pulmonology, Pleural cavity, Cancer, Sarcoidosis, Health, Asthma, Glen Burnie, Maryland, IP, Patient, Mercy Hospital, Diagnosis, Radiation, Nursing

BALTIMORE, Jan. 2, 2024 /PRNewswire-PRWeb/ -- The Lung Center at Mercy Medical Center is expanding to include Interventional Pulmonology (IP), Albert J. Polito, M.D., Medical Director of The Lung Center and Chief of the Division of Pulmonary Medicine at Mercy, has announced. The expansion will essentially double the size of Mercy's current Lung Center with greater access for pulmonary patients.

Key Points: 
  • Interventional Pulmonology (IP) at Mercy Provides Minimally Invasive Procedures to Diagnose & Treat Lung Disease, Cancer / Mercy First in Maryland to Offer New Integrated Robotic Lung Navigational Technology
    BALTIMORE, Jan. 2, 2024 /PRNewswire-PRWeb/ -- The Lung Center at Mercy Medical Center is expanding to include Interventional Pulmonology (IP) , Albert J. Polito, M.D.
  • , Medical Director of The Lung Center and Chief of the Division of Pulmonary Medicine at Mercy, has announced.
  • Beyond the downtown location, Mercy Lung Center staff see patients at the Overlea, Lutherville, Reisterstown, and Glen Burnie sites of Mercy Personal Physicians.
  • Founded in 1874 by The Sisters of Mercy, Mercy is home to the acclaimed Weinberg Center for Women's Health & Medicine and the $400+ million, 20-story Mary Catherine Bunting Center.

7,700 Resident Physicians Placed into Fellowship Training Positions through the NRMP's Medicine and Pediatric Specialties Match

Retrieved on: 
星期三, 十一月 29, 2023
Pediatrics, Cardiovascular disease, Annals of Pediatric Cardiology, Workforce, Cardiology, Medicine, National Resident Matching Program, Rheumatology, Patient, Immunology, BSN, Internal medicine, COVID-19, Hematology, NRMP, Doctor of Health Science, Geriatrics, MD, MBA, Ageing, Interventional pulmonology, Growth, Infection, Critical Care Medicine (journal), Nursing, Dentistry, Match, Gastroenterology, Oncology

WASHINGTON, Nov. 29, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released results for the 2023 Medicine and Pediatric Specialties Match, its largest fellowship Match encompassing 38 subspecialties. The 2023 Match featured an all-time high of 3,482 programs that certified a rank order list, marking a 3.6 percent increase in the number of programs over 2022. These programs collectively offered 9,068 positions, a 3.9 percent increase with 344 more positions than the previous year. Of these positions, 7,723 (85.2 percent) were filled when the matching algorithm was processed. While both the number of programs and positions increased by over three percent, the number of applicants certifying a rank order list for the Match saw a modest rise of only 35 applicants or 0.4 percent.

Key Points: 
  • WASHINGTON, Nov. 29, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released results for the 2023 Medicine and Pediatric Specialties Match, its largest fellowship Match encompassing 38 subspecialties.
  • "The growth of fellowship programs and positions in the Match reflect training opportunities and the future workforce trends of medical subspecialties.
  • Pediatric specialties offered 1,878 certified positions, filling 1,487 positions (79.2 percent), a decrease of 5.5 percent compared to last year.
  • Pediatric specialties filling over ninety-five percent of their positions include Pediatric Cardiology and Pediatric Hospital Medicine.

Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting

Retrieved on: 
星期二, 十月 3, 2023
Research, Clinical Trials, Biotechnology, Biometrics, Health, General Health, Other Science, Science, Oncology, Interventional pulmonology, High, Critical care, Comparison, HT, Medical college, ORACLE, Cancer, Lung cancer, Medical school, DO, Medical University of South Carolina, MD, Learning, Medical College of Wisconsin, Annual general meeting, PET/CT, Medical device, Medical imaging

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be presented at the CHEST Annual Meeting 2023 in Honolulu, Hawaiʻi.

Key Points: 
  • Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be presented at the CHEST Annual Meeting 2023 in Honolulu, Hawaiʻi.
  • These presentations will provide new insight on the clinical utility and real-world impact of the Nodify CDT and Nodify XL2 tests in the comprehensive management of lung nodules.
  • Dr. Kurman, remarked, "The data we're presenting at CHEST 2023 underscores the transformative potential of the Nodify XL2 test in managing all types of lung nodules.
  • However, published data shows that the performance of PET/CT imaging alone is compromised in assessing small lung nodules for cancer.

Body Vision Medical Introduces Latest Version of LungVision™ Software with Big Design Upgrade

Retrieved on: 
星期四, 八月 24, 2023
Interventional pulmonology, CT, UI, Feedback, Learning curve, Lung cancer, Artificial intelligence, Conference, Medical device

CAMPBELL, Calif., Aug. 24, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven intraoperative imaging has announced that it will preview its latest software version for its LungVision™ navigation and real-time imaging platform at the upcoming American Association for Bronchology and Interventional Pulmonology (AABIP) 2023 Annual Conference taking place on August 24-26 at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois. The latest LungVision™ software not only introduces a brand-new redesign of the user interface, but is packed with new features including an AI-driven suggested lesion location feature that assists with accurate localization of pulmonary lesions on the real-time, intraoperative images produced by the system during diagnostic bronchoscopy.

Key Points: 
  • "Our latest software release is the most extensive update to the user interface since LungVision's debut and delivers transformative improvements to the user experience," says Matt Baker, Body Vision Medical's Chief Operating Officer.
  • LungVision™ harnesses the power of artificial intelligence (AI) to seamlessly transform X-ray images acquired from any C-arm into real-time intraoperative CT scans.
  • Body Vision will be offering demonstrations of its LungVision™ system with the latest software designated as v.2.23 at the upcoming AABIP 2023 Annual Conference.
  • To learn more about Body Vision Medical, visit bodyvisionmedical.com .

Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer

Retrieved on: 
星期二, 八月 22, 2023
General Health, Health, Oncology, Interventional pulmonology, CT, Anxiety, Fear, ORACLE, Lung cancer, DO, Patient, Physician, Risk, Diagnosis, MPH, Conference, Biopsy, Medical imaging

The data will be presented by principal investigator of the ORACLE study, Michael Pritchett, DO, MPH, on Thursday, Aug. 24, 2023 in a live poster presentation in Chicago, IL.

Key Points: 
  • The data will be presented by principal investigator of the ORACLE study, Michael Pritchett, DO, MPH, on Thursday, Aug. 24, 2023 in a live poster presentation in Chicago, IL.
  • The Nodify XL2 test is designed to identify likely benign lung nodules that can be monitored with computed tomography (CT) scans instead of costly invasive procedures.
  • Additionally, the proportion of patients sent to CT surveillance with malignant nodules did not differ between the Nodify XL2 group and the control group.
  • “It is very encouraging that the Nodify XL2 test is helping physicians avoid unnecessary invasive procedures on benign lung nodules and prioritize patients with a higher risk of lung cancer.

The Inner Circle Acknowledges, Dr. Diana Kolman as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist

Retrieved on: 
星期四, 七月 6, 2023
Interventional pulmonology, Critical care, BS, Surgeon, Body cavity, Physician, Education, Internal medicine, COVID-19, Cancer, Respiratory system, Multimedia, American Thoracic Society, Senior, Lung, Inner circle, Rutgers University, Drexel, Cooper University Hospital, System, MD, Patient, Ross University School of Medicine, Child, American Board of Internal Medicine, Fellow, Physics, Capital Health, Temple University School of Medicine, Nursing care plan, Oncology, Smoking, Family, Mediastinum, Interior design, Nursing, Biology, Bronchoscopy

MOUNT LAUREL, N.J., July 6, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Diana Kolman is acknowledged as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist.

Key Points: 
  • MOUNT LAUREL, N.J., July 6, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Diana Kolman is acknowledged as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist.
  • Dr. Kolman began her pursuit of higher education at Rutgers University where she received a BS in Biology and Physics.
  • She is known for being clear and honest with her patients regarding their diagnoses and works to give them several options for treatment.
  • According to Dr. Kolman, the physicians at Capital Health – Pulmonology Specialists diagnose and treat conditions that affect the lungs and respiratory system.

First Use of the Galaxy System™ in the United States for Next Generation Robotic Bronchoscopy Conducted at the University of Chicago Medicine

Retrieved on: 
星期一, 五月 22, 2023
Interventional pulmonology, University, Macquarie University Hospital, Quality of life, Doctor of Philosophy, Lung, Journal, Patient, Physician, SAN, Fluoroscopy, Diagnosis, FDA, Biopsy, Medical device, MD

The procedure marks the commercial release of the robotic navigation system in the U.S. and comes on the heels of its recent FDA clearance .

Key Points: 
  • The procedure marks the commercial release of the robotic navigation system in the U.S. and comes on the heels of its recent FDA clearance .
  • The Galaxy System is designed so that physicians can more confidently navigate to and locate lung nodules during biopsy as part of a more effective and efficient bronchoscopy procedure.
  • “We designed the Galaxy System in collaboration with physicians to provide unique clinical value to patients and improved procedural efficiency.
  • To learn more about Noah Medical and the Galaxy System, please visit noahmed.com .

Journal of Bronchology & Interventional Pulmonology Publishes MATCH Study Results Confirming “Tool-in-Lesion” Accuracy of Noah Medical’s Galaxy System

Retrieved on: 
星期三, 四月 26, 2023
Interventional pulmonology, CBCT, Macquarie University Hospital, Tilt, Quality of life, Doctor of Philosophy, Journal, MD, Patient, Physician, SAN, Fluoroscopy, Diagnosis, FDA, Medical imaging, Galaxy

SAN CARLOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced that results from its MATCH Study, testing the “Tool-in-Lesion” accuracy of its Galaxy System™, are now available for review in the Journal of Bronchology & Interventional Pulmonology .

Key Points: 
  • SAN CARLOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced that results from its MATCH Study, testing the “Tool-in-Lesion” accuracy of its Galaxy System™, are now available for review in the Journal of Bronchology & Interventional Pulmonology .
  • The study found that the robotic platform’s TiLT+ Technology™ achieves 100% successful navigation to lesion, 100% diagnostic yield and 95% tool-in-lesion accuracy.
  • “The Galaxy System was designed in collaboration with physicians, for physicians,” said Jian Zhang, PhD, Noah Medical founder and CEO.
  • To learn more about Noah Medical and the Galaxy System, please visit noahmed.com .

AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

Retrieved on: 
星期四, 二月 23, 2023
ARMC, Johnson & Johnson, Doctor of Philosophy, Cancer, Diagnosis, EGG, Lung nodule, NYSE, Disease, AtlantiCare, Partnership, Interventional pulmonology, Risk, Survival rate, FDA, Oncology, Patient, CT, Lung cancer, American Lung Association, Heart & Lung, JNJ, Biopsy, Neoplasm, AtlantiCare Regional Medical Center, Mainland Campus, UKCA, Physician, Medical imaging, Medical device, Ethicon, EU

EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ -- AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum's Virtual Nodule Clinic. Located in New Jersey, it is integrating the innovative technology into its early lung cancer diagnosis program at its Heart & Lung and Cancer Care institutes at AtlantiCare Regional Medical Center (ARMC).

Key Points: 
  • Located in New Jersey, it is integrating the innovative technology into its early lung cancer diagnosis program at its Heart & Lung and Cancer Care institutes at AtlantiCare Regional Medical Center (ARMC).
  • Lung cancer is among the most common types of cancer and the leading cause of cancer deaths in the world, according to the American Lung Association .
  • Optellum's integrated Lung Cancer Prediction capability also helps AtlantiCare clinicians prioritize patients at high risk of having lung cancer.
  • "We have already identified suspicious tumors in individuals who have no known risk of lung cancer through this technology," added Borah.